Quercetin Clinical analysis

Quercetin Forms: Dihydrate, Phytosome, Liposomal and Glycosides

Compare quercetin dihydrate, phytosome, liposomal products, isoquercitrin and rutin, including actual quercetin content and the limits of absorption claims.

Published
Last reviewed
Reading time
7 min
Sources cited
7
Conceptual materials illustrating different supplement formulation approaches
On this page

Affiliate disclosure: Biohack Blueprint may earn a commission from qualifying DoNotAge purchases through our links.

Some delivery systems increase measured quercetin exposure in small human studies. That does not establish a universal best form, equal milligram doses or proportionally greater health benefits. Compare the actual quercetin content, the exact formulation studied and the outcome you care about.

A plain-language form guide

Form What the name means What to check
Aglycone / dihydrate Quercetin without an attached sugar; dihydrate includes water in the crystal form Declared quercetin amount and label convention
Phytosome A phospholipid-associated delivery complex Total complex weight versus quercetin provided
Liposomal A lipid-vesicle delivery approach Human data for the actual product, not the category name alone
Isoquercitrin / EMIQ Quercetin glycosides, including enzymatically modified forms Specific glycoside composition and tested dose
Rutin Quercetin attached to a particular sugar structure Do not equate rutin mass with pure quercetin mass

The formulation can matter, but the category does not replace a clear ingredient label or product-specific evidence.

What human absorption studies show

A small randomized crossover study in 12 healthy volunteers found greater exposure after a lecithin-based quercetin phytosome than after unformulated quercetin. It was an acute pharmacokinetic study, not an allergy, longevity or disease-outcome trial. [1]

A later synthesis of 31 human interventions found that chemical form and formulation can influence exposure. Comparisons were heterogeneous, with small studies, different doses and different measured analytes. A striking fold difference should stay attached to the exact comparison and sampling method. [2]

Delivery-system weight is not active content. Read both numbers before comparing products.
Delivery-system weight is not active content. Official labels; human formulation review PMID 40037045

Why “20 times more bioavailable” is not “20 times better”

Bioavailability concerns exposure, often summarized as the area under a concentration-time curve or peak concentration. A clinical benefit concerns an outcome such as symptom burden or blood pressure. The relationship can be nonlinear, absent or accompanied by different safety considerations.

Large exposure ratios also depend on the comparator. Comparing a specialized formulation with a poorly absorbed preparation does not prove the same ratio against every ordinary capsule or meal. Do not divide or multiply a label dose by an advertising number to make a personal dosing plan.

Complex weight versus active content

A front label can name a 250 mg complex while providing substantially less quercetin. An official Canadian NOW phytosome label explicitly distinguishes 250 mg complex from 80 mg quercetin. That clarity illustrates the question to ask of any delivery-system label. Manufacturer source.

DoNotAge Pure Quercetin instead states 400 mg quercetin per capsule and uses dihydrate. Its straightforward dose declaration is useful for label reading. It does not establish the highest absorption of all available forms, and the manufacturer’s broad bioavailability language should not be treated as a head-to-head clinical result.

More exposure is not proportional benefit. There is no universal milligram conversion calculator.
More exposure is not proportional benefit. PMIDs 30328058, 40037045

Foods and glycosides add another layer

Small human studies show that the sugar attached to quercetin can affect absorption. Food matrix, processing and the rest of a meal can also matter. Rutin, an onion glucoside and an isolated aglycone capsule should not be assumed to produce identical concentration curves. [3] [4] [5]

Circulating compounds are extensively conjugated and metabolized. Studies measuring free quercetin, total quercetin after deconjugation or selected metabolites may be answering different questions. That limits simple comparisons across unrelated graphs. [6]

Ask what the blood test actually measured

A pharmacokinetic paper may measure free quercetin, individual conjugates, or total quercetin after enzymes release the parent compound from conjugated metabolites. Those are different analytical quantities. Comparing two fold-increase headlines without checking the analyte, dose and comparator can create a false ranking.

The 31-study human absorption synthesis identified effects of chemical structure, delivery systems and food matrices. It also combined small and heterogeneous experiments. A ratio for one branded lecithin complex against its study comparator does not validate the same ratio for every product labelled “phytosome,” “liposomal” or “enhanced.” [2]

Four checks before accepting an absorption claim

Check Why it changes interpretation
Same active-quercetin amount? Complex weight and active content can differ
Same food conditions and sampling window? Meals and observation time affect exposure estimates
Same analyte and assay? Parent compound and conjugated metabolites are not interchangeable
Clinical outcomes also measured? An AUC increase alone cannot establish better symptom control

The randomized phytosome pharmacokinetic study involved 12 healthy volunteers and single-dose periods. It demonstrated a formulation-related exposure difference under the tested conditions, not superiority for blood pressure, allergy symptoms or lifespan. Symptom evidence must come from a separate clinical comparison. [1]

What this means for plain dihydrate

A straightforward dihydrate capsule can be a sensible product choice when clear active content, a simple formula and predictable pack cost are the priorities. It should not be described as universally the most bioavailable form. Conversely, lower measured exposure does not prove that every person needs to pay for a delivery complex.

Choose the clinical question first. If a particular formulation’s human trial is central to the decision, look for that preparation and its stated active content. If the priority is an uncomplicated quercetin-only product, compare ingredient transparency and serving arithmetic. Neither choice removes medicine interactions or fills gaps in long-term safety. [6] [7]

Choosing a form for a real purpose

If your interest comes from a particular clinical trial, match the studied form and active amount before generalizing its findings. If your priority is a simple supplement, focus on a clear dose, manageable capsule count, documented quality policy, cost and medication compatibility.

Liposomal terminology, a patented ingredient or a long ingredient list is not enough on its own to establish superior outcomes. Conversely, ordinary dihydrate is not rendered useless by the existence of newer delivery systems. The useful comparison is purpose, evidence, exposure, tolerability and value together.

Sources and next steps

Browse the complete 290-record Quercetin Data Center for the original studies, methods, disclosures and limitations. The numbered references below identify the sources used for this article; the full library also retains supporting and null evidence.

Continue by question: Quercetin Dosage: Reading Labels and Research Doses · Best Time to Take Quercetin: Meals, Morning or Night? · Foods High in Quercetin: Practical Sources and Portions · Best Quercetin Supplement: How to Choose the Right Formula.

Official DoNotAge Pure Quercetin 366-capsule jar

DoNotAge Pure Quercetin — 5/5 editorial rating

Our first choice for a straightforward single-active capsule: 400 mg quercetin per capsule, a vegan capsule and 60 or 366 capsules. The score assesses the formula, label clarity and practical product choice; clinical evidence is judged separately.

Read the full evidence-led review · View at DoNotAge. Use BB10 for 10% off eligible standalone products; confirm current checkout terms.

Affiliate disclosure: Biohack Blueprint may earn a commission from qualifying purchases. This is a desk-based editorial recommendation, not an independent batch assay or a promise of a health outcome.

Frequently asked questions

Is quercetin dihydrate a good form?

It is a straightforward commonly used form. Whether it suits a goal depends on the evidence, label, dose and individual circumstances; it is not proven universally superior.

Is liposomal quercetin always better?

No. Look for human data for the actual formulation and relevant outcomes rather than relying on the word liposomal.

Can I compare rutin and quercetin milligram for milligram?

No. Their chemical masses and absorption patterns differ, so a simple equal-mass comparison is misleading.

Is phytosome complex weight the same as active quercetin?

No. A phospholipid complex contains quercetin together with carrier material. Use the separately declared active content when it is available. The total complex weight should not automatically be compared milligram-for-milligram with isolated quercetin.

Does 20 times greater absorption mean 20 times better benefits?

No. An exposure ratio belongs to the tested formulation, comparator and assay. Clinical benefits may not increase proportionally, and a pharmacokinetic study does not establish a dose-conversion rule or an equivalent treatment effect.

Share this article

Send the research to someone who would find it useful.

Facebook X LinkedIn Reddit WhatsApp Email

Sources & article history

Sources (7)
  1. Antonella Riva, et al. Improved Oral Absorption of Quercetin from Quercetin Phytosome®, a New Delivery System Based on Food Grade Lecithin European journal of drug metabolism and pharmacokinetics. 2019;44(2):169-177.
  2. Lu Liu, et al. Improving quercetin bioavailability: A systematic review and meta-analysis of human intervention studies Food chemistry. 2025;477:143630.
  3. E U Graefe, et al. Pharmacokinetics and bioavailability of quercetin glycosides in humans Journal of clinical pharmacology. 2001;41(5):492.
  4. I Erlund, et al. Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers European journal of clinical pharmacology. 2000;56(8):545.
  5. Jihyun Lee, et al. Pharmacokinetics of quercetin absorption from apples and onions in healthy humans Journal of agricultural and food chemistry. 2012;60(15):3874.
  6. Gary Williamson, et al. A critical examination of human data for the biological activity of quercetin and its phase-2 conjugates Critical reviews in food science and nutrition. 2025;65(9):1669-1705.
  7. Susanne Andres, et al. Safety Aspects of the Use of Quercetin as a Dietary Supplement Molecular nutrition & food research. 2018;62(1):10.1002/mnfr.201700447.